Although, in the future, it will be important and necessary to clarify the relationship between c-Maf and these transporters, c-Maf has potential as a comprehensive therapeutic target in the treatment of not only diabetic nephropathy but also other diseases. This evidence concerns the gene MAF and diabetic kidney disease.